|
Centre for Policy on Ageing | |
 | |
|
Geriatric psychopharmacology | Author(s) | J Craig Nelson |
Publisher | Marcel Dekker, New York, 1998 |
Pages | 469 pp (Medical psychiatry, 9) |
Source | Marcel Dekker, Inc., Cimarron Road, PO Box 5005, Monticello, NY 12701-5185, USA. |
Keywords | Drugs ; Psychiatric treatment ; Mental disorder ; Depression ; Psychoses ; Anxiety ; Dementia ; Research. |
Annotation | Chapters on neurochemistry in ageing, pharmacokinetics, and drug interactions provide a foundation for subsequent chapters which focus on specific disorders. A section on depression - including a research review of maintenance therapies - deals with the treatment of major depression, psychotic depression, and major depressions during bereavement. Part 3 concerns the treatment of depression with associated conditions: cardiac disease, post-stroke psychiatric disorders, cancer, Parkinson's disease, dementia, and medical illness. Little has been written previously regarding treatment of geriatric patients with manic syndromes or bipolar disorders: the use of lithium, its toxicity, and the use of anti-convulsants are discussed. Sections 5 and 6 deal with late-life psychosis, and anxiety disorders (use of sedative hypnotics), including the treatment of generalised anxiety disorder, panic disorder, and obsessive-compulsive disorder. The final section, on dementia, discusses use of cognitive enhancers, neuroleptics for behavioural complications, and non-neuroleptic treatment of complications of dementia. (RH). |
Accession Number | CPA-980707209 B |
Classmark | LLD: LP: E: ENR: EL: ENP: EA: 3A |
Data © Centre for Policy on Ageing |
|
...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|